News und Analysen
Prediction: Here's Where UnitedHealth Stock Is Headed After Scaling Back Medicare Advantage Plans
Some might view UnitedHealth Group (NYSE: UNH) as a stock and a company in retreat. UnitedHealth's shares have plunged more than 40% below the high set in the fourth quarter of 2024. The health
Is AT&T Stock a Buy?
AT&T (NYSE: T) is the third-largest wireless carrier in the U.S., serving over 90 million customers. Wireless generates the majority of the company's roughly $120 billion in annual revenue. AT&T
EQS-News: Biotest AG: Cancellation of the extraordinary general meeting on 28 October 2025
AbbVie: Navigating Challenges and Seizing Opportunities in the Pharma Sector
Explore the exciting world of AbbVie (NYSE: ABBV) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends
AT&T Just Delivered for Investors. It's Not Too Late to Buy the Stock.
Telecom giant AT&T (NYSE: T) has a simple growth strategy: Win high-value customers who use its wireless and fiber services together. The company picked up plenty of those so-called "converged"
ASML Just Shared Fantastic News for Nvidia, Broadcom, and AMD Investors
On Wednesday, shares of ASML (NASDAQ: ASML) popped by 2.7% in response to its third-quarter earnings report. The artificial intelligence (AI) growth stock rose 16% from Sept. 15 to Oct. 15.
But it
2 Beaten-Down Stocks to Buy and Hold for the Next Decade
The market is forward-looking, but investors who earn better-than-average returns often look even further into the future and identify opportunities that are currently being overlooked. That means
Nvidia, Broadcom, and AMD Each Won Deals With OpenAI. Here's the Biggest Winner of the Bunch.
Recent weeks have been ripe with deals among artificial intelligence (AI) players. Words from Nvidia's (NASDAQ: NVDA) Jensen Huang during the company's earnings report in August set the stage for
J.L. Bainbridge Exits Most of Biogen Stake as Biotech Stock Eyes Turnaround
Florida-based wealth advisory J. L. Bainbridge & Co. sold 119,376 shares of Biogen (NASDAQ:BIIB) during the third quarter for an estimated $16.1 million.
In a quarterly disclosure filed with the
2 High-Yield Dividend Stocks Too Cheap to Ignore
What's even better than a solid, reliable dividend stock? A solid, reliable, high-yield dividend stock. One that is trading at attractive levels is even more preferable. Excellent dividend payers
My Favorite AI Growth Stock to Invest $1,000 in Right Now
When investors think about leading artificial intelligence (AI) growth stocks, names like Nvidia, Broadcom, and Advanced Micro Devices may come to mind. And while these three chip designers are
Are AMD and Nvidia Stocks a Buy After the Pullback?
In this video, I will cover recent updates regarding Advanced Micro Devices (NASDAQ: AMD) and Nvidia (NASDAQ: NVDA). Watch the short video to learn more, consider subscribing, and click the special
Whale Watching: Iconic Healthcare Stock Gains Additional Institutional Support, According to Recent Filing
Burns Matteson Capital Management, LLC reported a new stake in UnitedHealth Group (NYSE:UNH), acquiring 8,017 shares in the third quarter of 2025, an estimated $2.77 million trade as of the end of
Why Atai Life Sciences Stock Was So Lively This Week
Atai Life Sciences (NASDAQ: ATAI), a biotech focused on developing psychedelic-based medicines to treat mental health disorders, was a standout stock over the past few days in its rather limited
AMD's Recent Partnerships With OpenAI and Oracle Are Getting Some Wall-Street Analysts Extremely Bullish
In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD), Nvidia (NASDAQ: NVDA), and other AI stocks. To learn more, check out the short video, consider subscribing,
What AMD, Oracle, Nvidia, and Intel Shareholders Should Know About the Recent Flood of AI Updates
In today's video, I discuss recent updates impacting Advanced Micro Devices (NASDAQ: AMD), Nvidia (NASDAQ: NVDA), and other AI stocks. To learn more, check out the short video, consider subscribing,
Eli Lilly vs. Viking Therapeutics Stock: Which Is the Best Growth Opportunity, According to Wall Street?
Eli Lilly (NYSE: LLY) and Viking Therapeutics (NASDAQ: VKTX) offer investors the chance to invest in one of today's highest-potential industries: weight loss drugs. The market for these products
A Once-in-a-Decade Investment Opportunity: 1 Vanguard Index Fund to Buy for the AI Boom
Despite increased economic activity, U.S. electricity demand stagnated during the last two decades due to the introduction of energy-efficient technologies like LED lights and modern appliances
2 Surefire Dividend Stocks to Buy for the Long Haul
In 2022 and 2023, rising interest rates drove many income investors to sell their dividend stocks and buy risk-free CDs and T-bills for higher yields. But as interest rates decline again, many of
ASSET PLANNING Exits Full Stake in Pfizer Worth $2.7 Million
On October 16, 2025, ASSET PLANNING SERVICES INC /LA/ /ADV disclosed in an SEC filing that it sold out of Pfizer(NYSE:PFE), with an estimated $2.66 million trade.
According to a Securities and
1 Artificial intelligence (AI) Stock to Buy Before the End of 2025
Spending on artificial intelligence (AI) technology is accelerating among the biggest and most profitable companies in the world. The stellar performance of some of the leading chip stocks could be
QSM Asset Management Buys $6.8 Million of Pfizer Stock as Pharma Giant Lags Market
On Thursday, QSM Asset Management disclosed a significant buy of Pfizer (NYSE:PFE), adding shares worth an estimated $6.8 million in the third quarter.
QSM Asset Management increased its position in
2 Pharmaceutical Growth Stocks to Buy Now and Hold for Decades
Investing in pharmaceutical stocks can carry risks. It's not always clear which drugs will be successful and turn into blockbusters for their respective businesses. As a result, it can take years
A Once-in-a-Decade Investment Opportunity: 1 Pharmaceutical Stock to Buy Now Hand Over Fist and Hold for Years
Over the past decade, pharmaceutical maker Pfizer (NYSE: PFE) has severely lagged the market. Dividends reinvested aside, the stock is in the red over this period, while the S&P 500 is up by almost
Did Viking Therapeutics Just Say "Checkmate" to Eli Lilly?
Eli Lilly (NYSE: LLY) is the largest pharmaceutical (and healthcare) company in the world by market capitalization. It boasts more than 49,000 employees and currently leads the fast-growing market



